Related Experiment Video
Updated: Aug 22, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule
Chuan Xiao1, Tobias J Tuthill, Carol M Bator Kelly
1Department of Biological Sciences, Purdue University, 915 W. State St., West Layfayette, IN 47909-2054, USA.
Abstract:
Intercellular adhesion molecule 1 (ICAM-1) is the cellular receptor for the major group of human rhinovirus serotypes, including human rhinovirus 14 (HRV14) and HRV16. A naturally occurring variant of ICAM-1, ICAM-1Kilifi, has altered binding characteristics with respect to different HRV serotypes. HRV14 binds to ICAM-1 only transiently at physiological temperatures but forms a stable complex with ICAM-1Kilifi. Conversely, HRV16 forms a stable complex with ICAM-1 but does not bind to ICAM-1Kilifi. The three-dimensional structures of HRV14 and HRV16, complexed with ICAM-1, and the structure of HRV14, complexed with ICAM-1Kilifi, have been determined by cryoelectron microscopy (cryoEM) image reconstruction to a resolution of approximately 10 angstroms. Structures determined by X-ray crystallography of both viruses and of ICAM-1 were fitted into the cryoEM density maps. The interfaces between the viruses and receptors contain extensive ionic networks. However, the interactions between the viruses and ICAM-1Kilifi contain one less salt bridge than between the viruses and ICAM-1. As HRV16 has fewer overall interactions with ICAM-1 than HRV14, the absence of this charge interaction has a greater impact on the binding of ICAM-1Kilifi to HRV16 than to HRV14.
Insights
Intercellular adhesion molecule 1 (ICAM-1) binds human rhinoviruses (HRVs). A variant, ICAM-1Kilifi, alters binding, with HRV14 preferring it and HRV16 avoiding it, impacting viral interactions.
Area of Science:
- Structural biology
- Virology
- Immunology
Background:
- Intercellular adhesion molecule 1 (ICAM-1) serves as the cellular receptor for major human rhinovirus (HRV) serotypes.
- Naturally occurring ICAM-1 variants, like ICAM-1Kilifi, exhibit altered binding affinities for different HRV serotypes.
Purpose of the Study:
- To elucidate the structural basis for differential binding of HRV14 and HRV16 to ICAM-1 and its variant, ICAM-1Kilifi.
- To understand how variations in receptor-virus interactions affect binding stability and specificity.
Main Methods:
- Cryo-electron microscopy (cryoEM) image reconstruction determined the 3D structures of HRV-ICAM-1 and HRV-ICAM-1Kilifi complexes.
- X-ray crystallography structures of viruses and ICAM-1 were fitted into cryoEM density maps.
- Analysis of ionic networks and salt bridges at the virus-receptor interfaces.
Main Results:
- HRV14 binds ICAM-1 transiently but stably to ICAM-1Kilifi; HRV16 binds ICAM-1 stably but not ICAM-1Kilifi.
- Virus-receptor interfaces feature extensive ionic networks, with ICAM-1Kilifi complexes having one less salt bridge than ICAM-1 complexes.
- The reduced salt bridge in ICAM-1Kilifi complexes disproportionately affects HRV16 binding due to its inherently fewer interactions with ICAM-1.
Conclusions:
- Structural differences in ICAM-1 and its variant ICAM-1Kilifi dictate differential binding of HRV serotypes.
- The number and nature of ionic interactions at the interface are critical for the stability and specificity of HRV-receptor complexes.
- Understanding these molecular interactions provides insights into viral entry mechanisms and host-pathogen dynamics.
More Related Videos
06:44Confocal Imaging of Double-Stranded RNA and Pattern Recognition Receptors in Negative-Sense RNA Virus Infection
Published on: January 26, 2019
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Respiratory Syncytial Virus Disease
Inhibitors Of Virion Release
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...